Discover other firms ranked in Private Equity: Buyouts & Venture Capital Investment (International Firms)

4
Band 4
Morgan, Lewis & Bockius LLP
4
Morgan, Lewis & Bockius…
7 Years Ranked

View profile
Davis Polk & Wardwell LLP
4
Davis Polk & Wardwell LLP
11 Years Ranked

View profile
Ropes & Gray LLP
4
Ropes & Gray LLP
11 Years Ranked

View profile
5
Band 5
5
Baker McKenzie
4 Years Ranked

View profile
Cooley LLP
5
Cooley LLP
3 Years Ranked

View profile
Hogan Lovells
5
Hogan Lovells
5 Years Ranked

View profile

Chambers Review

Provided by Chambers
Private Equity: Buyouts & Venture Capital Investment (International Firms) - China
5
Band 5
What the Team is Known For

Paul Hastings advises on private equity deals for a client roster featuring Chinese and international private equity houses and funds. The team remains highly focused on private equity investments in the real estate sector, with the capacity to advise throughout Asia. It has a strong track record of handling TMT-related transactions.

Strengths

"We're really happy. They were able to link us up with people through their network too."

"They are very commercial and take a balanced approach, providing creative solutions in addition to standard legal advice."

"Paul Hastings is a very sophisticated firm."

Work Highlights

Paul Hastings advised GenScript Biotech and its subsidiary Probio Technology on Probio’s Series C financing, raising approximately USD224 million.

Notable practitioners

David Wang in Shanghai and Beijing is a key contact.